Bufo Alvarius: The Psychedelic Toad of the Sonoran Desert — Key Connections
One-line verdict: Hamilton Morris’s updated edition of the 1984 classic, now including a detailed NaBH4 reductive amination protocol for 5-MeO-DMT that serves as a direct chemical benchmark for the Paradisi group’s enzymatic cascade.
Why This Matters
Glenn’s group published a bi-enzymatic cascade to 5-MeO-tryptamine (ACS Catalysis 2025), making this text a concrete comparison point: the traditional chemical synthesis of the final N,N-dimethylation step that the enzymatic route aims to replace. The purification discussion (solvent switching, acid-base extraction, recrystallization, short-path distillation) maps directly onto downstream processing challenges in flow biocatalysis. The text also feeds into the Web of Psychedelics project as a primary source on Bufo alvarius venom chemistry and the conservation argument for synthetic 5-MeO-DMT.
Key Ideas
1. NaBH4 reductive amination at low temperature avoids Pictet-Spengler cyclization
The core synthetic insight: running reductive amination below 20 C with NaBH4 (instead of NaBH3CN) avoids beta-carboline side products because the borohydride intercepts the iminium intermediate faster than the competing intramolecular Pictet-Spengler cyclization can close the ring.
Connects to: Hitchhikers_Guide_to_Flow_Chemistry — the flow chemistry review discusses Pictet-Spengler reactions and temperature control in continuous flow, where precise thermal management is inherently easier than in batch. Connects to: paradisi_group_context — the group’s enzymatic route bypasses the selectivity problem entirely: tryptophanase (EcTnaA) and tryptophan decarboxylase (RgnTDC) produce 5-MeO-tryptamine without needing reductive amination or temperature-dependent selectivity control.
2. NaBH3CN leaves persistent cyanide-containing trace impurities
Morris reports that even after column chromatography and recrystallization, NaBH3CN-derived products retain cyanide-smelling impurities (likely amino-cyanoborane adducts or N-cyanomethyltryptamines). This is a practical safety and purity argument for switching reagents.
Connects to: paradisi_group_context — this impurity problem is one of the strongest arguments for biocatalytic routes: enzymes produce no cyanide-containing byproducts, and the aqueous reaction medium simplifies purification.
3. 5-Methoxytryptamine can be prepared from melatonin via base-catalyzed deacetylation
The text describes a route from melatonin (widely available sleep supplement) to 5-methoxytryptamine using NaOH in isoamyl alcohol at reflux, with sodium dithionite as reductant.
Connects to: Glossary — melatonin appears in the psychedelics glossary as a biosynthetic precursor in the tryptamine pathway, and the vault’s Huberman notes cover melatonin’s circadian role.
New territory — the melatonin-to-tryptamine chemical conversion has no existing vault coverage. Could be worth a short note in _RESEARCH/ comparing this chemical deacetylation to the enzymatic route using deacetylases.
4. Solvent switching via selective MeOH evaporation enables extraction
After reaction in MeOH (miscible with both water and organics), the MeOH is boiled off selectively (BP 64 C vs 100 C for water) until the remaining aqueous phase is polar enough for liquid-liquid extraction with EtOAc. The key is stopping at ~10% MeOH rather than going to dryness, to avoid the product crashing out as intractable tar.
Connects to: Solvent Switching in Continuous Multistep Chemoenzymatic Synthesis_ Telescoping Enzymatic Synthesis of Chiral, Pyridine-Containing Amines with Cross-Coupling as a Case Study — the Paradisi group’s own paper on solvent switching in continuous flow, which addresses the same fundamental problem (moving from aqueous enzymatic conditions to organic workup) but in a flow context using membrane separators rather than batch evaporation.
5. Acid-base extraction selectively isolates amines from complex mixtures
The purification relies on pulling the freebase amine into 3N HCl (protonates the amine, making it water-soluble), washing away neutral impurities in the organic phase, then basifying and re-extracting. This exploits the pKa difference between the target amine and neutral/acidic byproducts.
Connects to: paradisi_group_context — the group’s pipeline includes purification of amine products from enzymatic reactions. Acid-base extraction is directly applicable to isolating tryptamine products from biocatalytic cascades, since amino acid substrates (zwitterionic) stay in the aqueous phase while freebase amine products partition into organic solvent.
6. Short-path vacuum distillation as a scale-up purification strategy
For large-scale work, the text recommends short-path distillation over recrystallization to avoid vast solvent quantities. 5-MeO-DMT freebase boils at 160-170 C at 0.6 mm/Hg. The discussion extends to wiped-film and thin-film evaporators for thermally sensitive indoles.
Connects to: Hitchhikers_Guide_to_Flow_Chemistry — the flow chemistry review covers continuous downstream processing including in-line distillation, which connects to the residence-time-at-temperature principle that makes WFE preferable to batch distillation for sensitive compounds.
7. Water concentration must stay below 10% to maintain solvent amphiphilicity
A practical rule: too much water causes tryptamine freebases to precipitate as intractable tar that traps stir bars and resists redissolution. The MeOH/water ratio must preserve amphiphilicity so both polar NaBH4 and nonpolar tryptamine stay in solution.
New territory — no existing vault notes cover solvent system design for tryptamine solubility. The principle (balancing polar/nonpolar solubility in a single phase) is relevant to buffer optimization in enzymatic tryptamine synthesis.
8. Conservation argument: synthetic production protects wild toad populations
The synthesis appendix was added to the 6th edition explicitly to reduce harvesting pressure on Bufo alvarius. Morris frames synthetic 5-MeO-DMT as both greener and more sustainable than toad-derived material.
Connects to: DMT — the DMT substance page covers the natural occurrence of tryptamines in plants and animals, and the broader question of natural vs synthetic sourcing. Connects to: HamiltonMorris133 — Gallimore and Morris discuss the vision for self-sufficient chemical synthesis infrastructure to reduce dependence on natural sources.
9. TLC monitoring with 4:1 MeOH:EtOAc resolves tryptamine intermediates
The Rf order (5-MeO-T < 5-MeO-NMT < 5-MeO-DMT < 6-MeO-THBC) provides a practical analytical handle for reaction monitoring. The text notes a better system: pure ethanol or methanol with 1% triethylamine.
New territory — no vault notes cover TLC conditions for tryptamine analysis. Relevant if the Paradisi group needs to monitor tryptamine cascades by TLC in addition to HPLC/MS.
10. Formaldehyde addition rate must exceed NaBH4 addition rate
Because the NaBH4 solution is more concentrated (1.57 mol/100 mL vs 1.34 mol/100 mL for formaldehyde), the formaldehyde must be added faster to prevent excess borohydride from reducing formaldehyde to methanol before it can condense with the amine. This is a kinetic competition for the same electrophile.
Connects to: paradisi_group_context — analogous to substrate feeding strategies in enzymatic cascades, where the ratio of substrates fed to a multi-enzyme system determines selectivity. The group’s flow reactors use residence time and feed ratios to control exactly this type of competing-pathway problem.
Connection Map
| This source says… | …which links to | Because |
|---|---|---|
| NaBH4 at 0 C avoids Pictet-Spengler | Hitchhikers_Guide_to_Flow_Chemistry | Flow reactors give superior temperature control for this exact selectivity problem |
| Enzymatic route is “greener” than NaBH4 | paradisi_group_context | The Paradisi group’s ACS Catal. 2025 paper demonstrates this with a two-enzyme cascade |
| Solvent switch by selective evaporation | Solvent Switching in Continuous Multistep Chemoenzymatic Synthesis_ Telescoping Enzymatic Synthesis of Chiral, Pyridine-Containing Amines with Cross-Coupling as a Case Study | Same problem solved in flow with membrane separators |
| Synthetic 5-MeO-DMT protects toads | DMT, HamiltonMorris133 | Conservation argument parallels growing demand documented in the Web of Psychedelics |
| 5-MeO-DMT as potent psychedelic | 04_Psychedelics, NOTES_5-MeO-DMT_intranasal_phase1 | Pharmacological and phenomenological characterization in the EM framework |
Cross-Domain Bridges
Research to Creative: The Paradisi group’s enzymatic tryptamine cascade (research) directly addresses the conservation problem Morris raises (creative/psychedelics). The group’s ACS Catalysis paper is, in effect, the academic answer to the question this pamphlet poses: how to make tryptamines sustainably without chemical waste or toad harvesting. This is a rare case where Glenn’s research program and his psychedelics interest project converge on the same molecule.
Synthesis to Phenomenology: The purification challenges (colored impurities from indole oxidation, beta-carboline side products) are not just synthetic nuisances. Beta-carbolines like pinoline are themselves psychoactive (MAO inhibition), meaning impure 5-MeO-DMT would produce pharmacologically different experiences than pure material. The purity discussion connects directly to the phenomenological mapping in NOTES_5-MeO-DMT_intranasal_phase1, where dose-response precision depends on compound purity.
Open Questions
- Could the Paradisi group’s tryptophanase/decarboxylase cascade be extended with a methyltransferase to go all the way to 5-MeO-DMT (not just 5-MeO-tryptamine), eliminating the need for any chemical N-methylation step?
- What is the actual logP difference between 5-MeO-DMT and DMT (without the methoxy group), and how does this quantitatively affect extraction efficiency from aqueous biocatalytic reaction mixtures?
- Are the beta-carboline side products (pinoline, N-methyl-pinoline) that form during Pictet-Spengler cyclization pharmacologically relevant contaminants in toad-derived 5-MeO-DMT preparations?